Globus Medical, Inc. logo

Globus Medical, Inc. (GM0N)

Market Closed
14 Aug, 15:30
XETRA XETRA
74. 08
0
0%
- Market Cap
48.4 P/E Ratio
- Div Yield
5 Volume
2.69 Eps
74.08
Previous Close
Add Transaction
Day Range
74.08 74.08
Year Range
66.3 75.28
Want to track GM0N and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GM0N closed yesterday higher at €74.08, an increase of 0% from Thursday's close, completing a monthly increase of 9.9762% or €6.72. Over the past 12 months, GM0N stock gained 5.6776%.
GM0N is not paying dividends to its shareholders.
The last earnings report, released on May 14, 2026, missed the consensus estimates by -0.88%. On average, the company has fell short of earnings expectations by -0.6467%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

GM0N Chart

Globus Medical (GMED) Upgraded to Strong Buy: Here's Why

Globus Medical (GMED) Upgraded to Strong Buy: Here's Why

Globus Medical (GMED) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 4 days ago
GMED vs. ITGR: Which Stock Is the Better Value Option?

GMED vs. ITGR: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks is more attractive to value investors?

Zacks | 4 days ago
Globus Medical Q2 Earnings Call Highlights

Globus Medical Q2 Earnings Call Highlights

Globus Medical NYSE: GMED reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling technologies and Nevro sales. The company reaffirmed its full-year revenue outlook while raising its adjusted earnings forecast, citing margin expansion and operating leverage in the first half.

Marketbeat | 1 week ago

Globus Medical, Inc. (GM0N) FAQ

What is the stock price today?

The current price is €74.08.

On which exchange is it traded?

Globus Medical, Inc. is listed on XETRA.

What is its stock symbol?

The ticker symbol is GM0N.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Globus Medical, Inc. ever had a stock split?

No, there has never been a stock split.

Globus Medical, Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Keith W. Pfeil CEO
XETRA Exchange
US3795772082 ISIN
US Country
6,000 Employees
- Last Dividend
- Last Split
3 Aug 2012 IPO Date

Overview

Globus Medical, Inc. is a prominent medical device company focused on innovating healthcare solutions for patients dealing with musculoskeletal disorders, serving both the United States and international markets. Since its inception in 2003, Globus Medical has been at the forefront of developing a wide range of medical devices aimed at improving the quality of life for patients suffering from a variety of conditions, including degenerative and congenital disorders, deformities, tumors, and trauma injuries. With its headquarters located in Audubon, Pennsylvania, Globus Medical has established a strong global presence, distributing its products through a mix of direct sales, distributor representatives, and independent sales agents.

Products and Services

Globus Medical, Inc. offers an extensive portfolio of products and solutions across multiple domains within the musculoskeletal treatment spectrum:

  • Spine Products: This category includes traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices designed for treating a range of conditions from degenerative diseases to trauma injuries. Additionally, motion preservation technologies such as dynamic stabilization, total disc replacement, and interspinous distraction devices are available for patients seeking alternatives to traditional spine fusion procedures.
  • Interventional Solutions: Aimed at treating vertebral compression fractures, the company offers a variety of minimally invasive options that cater to this common yet painful consequence of osteoporosis and other conditions leading to weakened bones.
  • Regenerative Biologic Products: In pursuit of aiding the body's natural healing process, Globus Medical provides an assortment of regenerative products including both allografts (donated human tissue) and synthetic alternatives, enabling a broad range of applications from bone growth to tissue repair.
  • Orthopedic Trauma: For treating injuries related to trauma, the company offers a comprehensive suite of products including fracture plates, compression screws, intramedullary nails, and external fixation systems, facilitating the proper alignment and stabilization needed for effective healing.
  • Hip and Knee Joint Solutions: Focusing on joint replacement, Globus Medical provides modular hip stems and acetabular cups for hip surgeries, along with posterior stabilizing and cruciate retaining knee arthroplasty implants for knee replacement surgeries. These options offer customized solutions designed to meet the varying needs of patients undergoing joint replacement procedures.

Apart from its direct contribution to improving patient outcomes with its products, Globus Medical also engages in the distribution of human cell, tissue, and cellular and tissue-based products, leveraging its extensive network to facilitate availability across its served markets.

Contact Information

Address: 2560 General Armistead Avenue
Phone: 610 930 1800